High-flow Nasal Oxygenation During Preoxygenation and Atelectasis
Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Jan 3, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a method called high-flow nasal oxygenation during a process called preoxygenation, which happens before patients receive general anesthesia for surgery. The goal is to see if using high-flow nasal oxygen can help reduce a common problem called atelectasis, where part of the lung collapses, especially in obese patients. This condition can lead to breathing difficulties after surgery, so finding effective ways to prevent it is important.
To participate in this study, you need to be an adult who is scheduled for surgery lasting at least two hours and has a body mass index (BMI) of 30 or more. You will need to provide consent to take part. If you have certain medical conditions, such as severe heart or lung disease, or if you've had previous problems with breathing or surgeries in the head and neck area, you may not be eligible. Participants will receive high-flow nasal oxygen during the preoxygenation phase, and your progress will be monitored to help researchers understand the treatment's effectiveness. If you are interested in joining, the trial is currently recruiting participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults patients undergoinig surgery under general anesthesia with a BMI of 30 kg/m2 or greater who have given informed consent
- Exclusion Criteria:
- • surgery time less than 2 hours
- • Nasotracheal intubation
- • Severe cardiac or respiratory disease
- • History of difficult airway
- • History of a surgery or anatomical anomaly in the head and neck
- • History of Inability to breathe through nose
- • Gastric reflux disease
About Seoul National University Hospital
Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Trial Officials
TAE KYONG KIM
Principal Investigator
SMG-SNU Boramae Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported